Thank you for doing this life-saving research.
17.02.2026 19:17
👍 1
🔁 0
💬 0
📌 0
Thank you for doing this life-saving research.
Elevated blood levels of soluble E-cadherin are linked to increased risk of brain metastasis in inflammatory breast cancer, highlighting a potential target for therapy and risk assessment.
This.
Hone your #advocacy skills and learn the important basics of #breastcancer science, research methodology, and trial design. Apply to attend NBCC’s 2026 Project LEAD Institute today! For more information, visit: https://nbcc.info/ProjectLEADInstitute
More insights on this unethical vaccine study - which is paid for by the CDC and involves experimenting on a vulnerable infant population.
From in silico prediction to experimental validation: Identification of drugs and novel synergistic combinations that inhibit growth of inflammatory breast cancer cells https://www.biorxiv.org/content/10.64898/2025.12.10.693562v1
UNITE to help end breast cancer at the #NBCCSummit! Join tireless and talented breast cancer advocates who will help NBCC achieve our mission to end breast cancer for everyone. Nbcc.info/26Summit
All of this. Especially for MBC but for all patients. #cansky
Chemo = brain fog. Chemo + hormone suppression = more brain fog. You don’t say. Seriously, though, I am glad to see it’s getting studied. jamanetwork.com/journals/jam...
When ProPublica’s @gingerthompson.bsky.social began talking to people in Albany, GA, she didn’t expect that they would be so fearful to criticize the town’s sole hospital on the record — or how powerless they were to hold that hospital to account.
Read our 5-part "Sick in a Hospital Town" series:
"New research finds the latest quirk of #GLP-1 receptor agonists is that they may influence the interpretation of oncological #FDG PET/CT scans. 'We noticed unusual uptake in 1 of our pts on a GLP-1 agonist, which prompted a wider review.' The team conducted a retrospective case ..." 1/3 #CanSky
Inflammatory breast cancer is very aggressive.
The aggressive biology of IBC may override any additional risks imposed by a postpartum diagnosis.
pubmed.ncbi.nlm.nih.gov/40938309/
📢 Hot from the Press: Now published in #NEJM!
We are excited to share that the pivotal DESTINY-Breast05 data „Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer“ presented by Sibylle Loibl at #SABCS2025, is now available.
🔗 Read the full NEJM article:
www.nejm.org/doi/full/10....
MRIs are still the gold standard for inflammatory breast cancer.
So interesting listening to @tmprowell.bsky.social and other FDA oncologists on an Alamo Advocate panel. Thank you so much for being there and answering patient advocate questions. #sabcs2025
Partners in Progress: This #SABCS25 Plenary Lecture will showcase how patients and advocates have expanded their roles in every stage of breast cancer research—including clinical trial design. Learn more in SABCS Meeting News:
buff.ly/yKwCDRx
Presenters share the latest cutting-edge research—including data from the ALTERNATE, I-SPY, and MARRES trials—during a Rapid Fire session at #SABCS25.
Excellent talk this afternoon on dormant cell research and ways of targeting those cells to prevent recurrence. Important for all breast cancer survivors, but especially IBC patients. #sabcs2025 #inflammatorybreastcancer
San Antonio Breast Cancer Symposium 2025 Top 10 Abstracts Suggested by Paolo Tarantino
@ptarantinomd.bsky.social
@sabcs.bsky.social
oncodaily.com/voices/breas...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SABCS #SABCS2025
AACR Announces 2025 Breast Cancer Research Award Recipients Ahead of SABCS 2025
@theaacr.bsky.social
@sabcs.bsky.social
@stolaney1.bsky.social
oncodaily.com/industry/aac...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR #BreastCancer #SABCS #SABCS2025
Excited to be at SABCS, the largest breast cancer symposium in the world #alamoadvocateprogram #sabcs2025 #thinkibc
Guideline concordant care rates in IBC dropping over time
Conference attendees at IBCCC
Such wonderful networking and brainstorming today at the IBC Connect and Community - we will create an email distribution to connect clinician and community teams, interested in projects and ideas to improve adherence to guidelines for IBC- Please DM if you would like to join the list! #cansky
“If your doctor first treats the symptoms as an infection and they don’t improve within a week, ask for more tests, such as imaging or a biopsy, to find the cause. If redness or swelling continues, especially if you’re not breastfeeding, ask for a follow-up visit right away.”
I wish your friend well. Obamacare saved my life. I lost my health insurance in Aug of 2016. Found a lump Oct 2016. Signed up for ACA insurance Jan 2017 and started treatment for my Stage III TN IBC(Triple Negative Inflammatory Breast Cancer) which is also a death sentence without treatment.
Honored to be a presenter at IBC Community Connect Conference - it’s wonderful to be in the presence of so many brilliant, dedicated people. #IBCCC2025 Thank you @ibcradiation.bsky.social for bringing everyone together.
A flow chart comparing illness script-based vs pathophysiological approach to patient diagnosis. It starts with symptoms & lab values, diverges into two approaches, and then converges on potential diagnoses and treatments.
💬 Viewpoint: Medical education should shift from pattern recognition to critical thinking and pathophysiological reasoning to reduce diagnostic errors and adapt to #AI advancements. #MedEd
ja.ma/46VhjuI
Looking forward to reading this one.
Important, evidence-based information about birth control pills.
Epigenetic Modifiers in Cancer Therapy: Unlocking New Treatment Pathways
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EpigeneticModifiers #CancerTherapy